Dr. Bridget Hindman join DAVA CRO in August 2018, where she works on a variety of projects relating to acute myeloid leukemia. She received a Bachelor of Science in Molecular Biology and Criminology from the University of Texas at Dallas, and then attended West Virginia University, where she earned a PhD in Cancer Cell Biology. Her dissertation work focused on the role of motor proteins in cancer cell interactions with the surrounding collagen matrix and the resulting changes in the mechanobiology of the matrix. Through her participation in NIH funded training grants, Dr. Hindman gained knowledge and experience in a wide variety of biomedical research topics and worked with a team of graduate students across several institutions to host a regional conference funded by the American Society for Cell Biology.
Dr. Hindman then transitioned into a postdoctoral position at the National Institute for Occupational Safety and Health where she received training in toxicology and worked on research projects related to the role of occupational exposure to nanoparticles in the development of pulmonary fibrosis. During her PhD and postdoctoral training Dr. Hindman authored several research articles, a book chapter, and presented in many conference presentations.